机构：[1]State Key Laboratory of Genetic Engineering, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Cancer Institutes, Shanghai, China.[2]Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[3]Beijing Key Laboratory of Tumor Systems Biology, School of Basic Medical Sciences, Institute of Systems Biomedicine, Peking University Health Science Center, Beijing, China.[4]State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.[5]Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education and State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
We thank Dr. Kailin Yang of the Department of Radiation Oncology,
Taussig Cancer Center, Cleveland Clinic, for helpful discussion
and revision of this manuscript. This work was supported by the National
Natural Science Foundation of China (82325039, 82273255,
81822034, and 81821002), National Key Research and Development
Program of China (2022YFA1106600), and Direct Scientific Research
Grants from West China Second Hospital, Sichuan University
(KS021 and K1907) to S. Zhou, the CAMS Innovation Fund for
Medical Sciences (2023-I2M-2-004) to Z. Liu, National Key Research
and Development Program of China, Stem Cell and Translational
Research (2022YFA1105200), the National Natural Science Foundation
of China (82273117 and 92359303), Sichuan Science and Technology
Program (2023ZYD0128 and 2024NSFSC0059), and the West
China Hospital of Sichuan University 1·3·5 project for disciplines
of excellence (ZYYC23023) to Y. Wang, National Natural Science Foundation of China Grant (81972662) to J. Feng, and National
Key Research and Development Program of China (2023YFC2506400
and 2020YFA0112300) and National Natural Science Foundation of
China (82230103, 81930075) to S. Liu.
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2024]版：
无
最新[2023]版：
大类|1 区医学
小类|1 区肿瘤学
第一作者：
第一作者机构：[1]State Key Laboratory of Genetic Engineering, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Cancer Institutes, Shanghai, China.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Liu Suling,Wang Yuan,Feng Jiawen,et al.Building an Organ-Wide Macroscopic View of Cancer Hallmarks[J].Cancer Discovery.2024,14(11):2041-2046.doi:10.1158/2159-8290.CD-24-0833.
APA：
Liu Suling,Wang Yuan,Feng Jiawen,Liu Zhihua&Zhou Shengtao.(2024).Building an Organ-Wide Macroscopic View of Cancer Hallmarks.Cancer Discovery,14,(11)
MLA：
Liu Suling,et al."Building an Organ-Wide Macroscopic View of Cancer Hallmarks".Cancer Discovery 14..11(2024):2041-2046
医学